Nimbus Therapeutics - Funding, Financials, Valuation, Investors - Cointime

Bitcoin $63,464.28 +2.09%
Ethereum $1,681.46 +2.87%
BNB $607.40 +1.80%
Optimism $0.10 +2.96%
Arbitrum $0.08 +2.04%
Solana $67.29 +2.99%
Polygon $0.22 +2.77%
Cosmos $1.78 +5.38%
Avalanche $6.82 +1.88%

Bitcoin $63,464.28 +2.09%
Ethereum $1,681.46 +2.87%
BNB $607.40 +1.80%
Optimism $0.10 +2.96%
Arbitrum $0.08 +2.04%
Solana $67.29 +2.99%
Polygon $0.22 +2.77%
Cosmos $1.78 +5.38%
Avalanche $6.82 +1.88%

Nimbus Therapeutics

company

Investors

Number of Lead Investors

Number of Investors

7

17

Nimbus Therapeutics is funded by 17 investors. Access Biotechnology and Atlas Venture are the most recent investors.

Investor Name	Lead Investor	Funding Round
Access Biotechnology	-	Series Unknown
Atlas Venture	-	Series Unknown
Bain Capital Life Sciences	-	Series Unknown
Bill Gates	-	Series Unknown
Biotechnology Value Fund	-	Series Unknown
Lightstone Ventures	-	Series Unknown
Pfizer Venture Investments	-	Series Unknown
RA Capital Management	-	Series Unknown
SR One	-	Series Unknown
SV Health Investors	-	Series Unknown
Commodore Capital	-	Series Unknown
Logos Capital	-	Series Unknown
Surveyor Capital	-	Series Unknown
BVF Partners	-	Series Unknown
Lilly Ventures	-	Series C
Schrödinger	-	Series C
Richard Friesner	-	Seed